Suchergebnisse
Is SoFi Select 500 ETF (SFY) a Strong ETF Right Now?
Launched on 04/11/2019, the SoFi Select 500 ETF (SFY) is a smart beta exchange traded fund offering broad exposure to the Style Box - Large Cap Growth category of the market.
What Are Smart Beta
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund launched on 06/23/2005.
What Are
Aumann Q2 Earnings Call Highlights
Key Points
- Interested in Aumann AG? Here are five stocks we like better.
- Aumann’s first-half performance declined as cautious automotive investment pressured e-mobility: revenue fell 35% to
CHRD Jumps 14.1% in a Month, but Can the Rally Keep Running Higher?
Chord Energy Corporation CHRD shares have climbed 14.1% in the past month, putting the stock’s recent momentum in focus. The key question is whether better operating performance and cash generation
TXN's $5.8B Shareholder Returns: Can FCF Support Bigger Payouts Ahead?
Texas Instruments Incorporated TXN is showing that its improving business momentum is translating into stronger cash generation, raising the question of whether bigger shareholder payouts could
Why Casey's General Stores (CASY) is a Top Stock for the Long-Term
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Can BWX Technologies' Nuclear Medicine Expansion Boost Growth?
BWX Technologies, Inc. BWXT is broadening its commercial nuclear portfolio through expanded capabilities in nuclear medicine and medical radioisotopes. The company's acquisition of Kinectrics in May
Can FANG's Higher 2026 Output Guidance Keep Earnings Momentum Alive?
Diamondback Energy, Inc. FANG raised its 2026 production outlook after a second quarter that topped earnings expectations, while leaving its full-year capital budget unchanged. That combination puts
Pershing Square H1 Earnings Call Highlights
Key Points
- Interested in Pershing Square Holdings? Here are five stocks we like better.
- Pershing Square Ventures is targeted for a fall or year-end launch as a permanent-capital vehicle
MiNK Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in MiNK Therapeutics, Inc.? Here are five stocks we like better.
- MiNK initiated a randomized Phase II trial of off-the-shelf agenT-797 plus standard care for acute lung
GOOGL Down 19% From 52-Week High: Buy, Sell or Hold the Stock?
Alphabet GOOGL shares closed at $343.54 on Wednesday, a drop of 19% from the 52-week high of $408.61 on May 18. The decline can be attributed to rising capital expenditure as GOOGL focuses on
Asian Market Circuit Breakers Hit Stocks, Not AI Demand
Key Points
- Interested in NVIDIA Corporation? Here are five stocks we like better.
- South Korean margin debt and Japanese Yen carry-trade unwinds, not weakening AI or chip demand, are identified as
Is CEG's Nuclear Fleet Positioned to Support Long-Term Growth?
Constellation Energy’s CEG nuclear fleet is benefiting from rising demand for reliable, carbon-free electricity. Growing customer interest in long-term nuclear contracts further supports revenue
Innventure Q2 Earnings Call Highlights
Key Points
- Interested in Innventure, Inc.? Here are five stocks we like better.
- Accelsius’ outlook was materially reduced: Innventure withdrew its prior forecast for near-breakeven cash flow and
Heartflow Q2 Earnings Call Highlights
Key Points
- Interested in Heartflow, Inc.? Here are five stocks we like better.
- Strong second-quarter growth: Revenue rose 48% year over year to $64.1 million, while global case volume increased
Promis Neurosciences Q2 Earnings Call Highlights
Key Points
- Interested in Promis Neurosciences? Here are five stocks we like better.
- PMN310’s Phase 1b interim results showed a favorable safety profile: No ARIA-E cases, no treatment-related
Zwei Unternehmen, bei denen Cashflow auf neue Wachstumschancen treffen!
GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting
GRAIL (NASDAQ:GRAL) Chief Financial Officer Aaron Freidin said the company’s Galleri multi-cancer early detection test recorded strong
Wolverine World Wide Q2 Earnings Call Highlights
Wolverine World Wide (NYSE:WWW) reported second-quarter fiscal 2026 results that exceeded its outlook, led by continued
Ultrapar Participacoes Q2 Earnings Call Highlights
Ultrapar Participacoes (NYSE:UGP) reported higher second-quarter earnings, record operating cash generation and its lowest leverage level since 2008



